Stockreport

BioCryst Pharmaceuticals Non-GAAP EPS of -$0.07 misses by $0.01, revenue of $117.09M beats by $3.09M [Seeking Alpha]

BioCryst Pharmaceuticals, Inc.  (BCRX) 
Last biocryst pharmaceuticals, inc. earnings: 3/5 07:05 am Check Earnings Report
US:NASDAQ Investor Relations: biocryst.gcs-web.com/investor-relations
PDF Company introduces full-year 2024 total product revenue guidance of $443-$448 million based on additional 2024 revenue from RAPIVAB More on BioCryst Pharmaceuticals [Read more]